These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36206810)

  • 41. Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis.
    Morita A; Okubo Y; Morisaki Y; Torisu-Itakura H; Umezawa Y
    Dermatol Ther (Heidelb); 2022 Feb; 12(2):481-494. PubMed ID: 34967916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP).
    Burden AD; Mrowietz U; Skalicky AM; Rentz AM; Esser D; Gloede T; Thoma C; Menter A
    Dermatol Ther (Heidelb); 2022 Jun; 12(6):1367-1381. PubMed ID: 35590037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.
    Boehner A; Navarini AA; Eyerich K
    Exp Dermatol; 2018 Oct; 27(10):1067-1077. PubMed ID: 29852521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A narrative review of studies assessing the quality of life in patients with generalized pustular psoriasis.
    Patel PM; Sanchez-Melendez SN; Nambudiri VE
    Exp Dermatol; 2023 Aug; 32(8):1227-1234. PubMed ID: 36922363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical features and course of generalized pustular psoriasis in Korea.
    Jin H; Cho HH; Kim WJ; Mun JH; Song M; Kim HS; Ko HC; Kim MB; Kim H; Kim BS
    J Dermatol; 2015 Jul; 42(7):674-8. PubMed ID: 25819215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
    Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
    J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sociodemographic, clinical, laboratory, treatment and prognostic characteristics of 156 generalized pustular psoriasis patients in Turkey: a multicentre case series.
    Kara Polat A; Alpsoy E; Kalkan G; Aytekin S; Uçmak D; Yasak Güner R; Topkarcı Z; Yılmaz O; Emre S; Borlu M; Türkoğlu Z; Özkök Akbulut T; Özaydın Yavuz G; Kaya Erdoğan H; Adışen E; Satılmış Kaya A; Oğuz Topal I; Yazıcı S; Yılmaz E; Koku Aksu AE; Kartal SP; Deveci BN; Öksüm Solak E; Karadağ AS; Sarıkaya Solak S; Kıvanç Altunay I; Türel Ermertcan A; Özkesici Kurt B; Gelincik Kaçar N; Ataseven A
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1256-1265. PubMed ID: 35348254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis and screening of patients with generalized pustular psoriasis.
    Ly K; Beck KM; Smith MP; Thibodeaux Q; Bhutani T
    Psoriasis (Auckl); 2019; 9():37-42. PubMed ID: 31417859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutation analysis of the IL36RN gene in Chinese patients with generalized pustular psoriasis with/without psoriasis vulgaris.
    Li X; Chen M; Fu X; Zhang Q; Wang Z; Yu G; Yu Y; Qin P; Wu W; Pan F; Liu H; Zhang F
    J Dermatol Sci; 2014 Nov; 76(2):132-8. PubMed ID: 25212972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic Burden of Generalized Pustular Psoriasis in Sweden: A Population-Based Register Study.
    Löfvendahl S; Norlin JM; Schmitt-Egenolf M
    Psoriasis (Auckl); 2022; 12():89-98. PubMed ID: 35548662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathophysiology of generalized pustular psoriasis.
    Iizuka H; Takahashi H; Ishida-Yamamoto A
    Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S55-9. PubMed ID: 12677433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum Procalcitonin and Presepsin Levels in Patients with Generalized Pustular Psoriasis.
    Nagai M; Imai Y; Wada Y; Kusakabe M; Yamanishi K
    Dis Markers; 2018; 2018():9758473. PubMed ID: 30647802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generalized Pustular Psoriasis: Clinical Management and Update on Autoinflammatory Aspects.
    Takeichi T; Akiyama M
    Am J Clin Dermatol; 2020 Apr; 21(2):227-236. PubMed ID: 31813117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A narrative review of the socioeconomic burden associated with generalised pustular psoriasis.
    Zimmermann TM; Hofmann P; Chiu GR
    Exp Dermatol; 2023 Aug; 32(8):1219-1226. PubMed ID: 37309747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan.
    Miyachi H; Konishi T; Kumazawa R; Matsui H; Shimizu S; Fushimi K; Matsue H; Yasunaga H
    J Am Acad Dermatol; 2022 Jun; 86(6):1266-1274. PubMed ID: 34116101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generalized pustular psoriasis: current management status and unmet medical needs in Japan.
    Komine M; Morita A
    Expert Rev Clin Immunol; 2021 Sep; 17(9):1015-1027. PubMed ID: 34402355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis: A PRISMA-compliant systematic review and meta-analysis.
    Liu ZJ; Tian YT; Shi BY; Zhou Y; Jia XS
    Medicine (Baltimore); 2020 Nov; 99(45):e23068. PubMed ID: 33157966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An update on generalized pustular psoriasis.
    Gooderham MJ; Van Voorhees AS; Lebwohl MG
    Expert Rev Clin Immunol; 2019 Sep; 15(9):907-919. PubMed ID: 31486687
    [No Abstract]   [Full Text] [Related]  

  • 59. Improved quality of life of patients with generalized pustular psoriasis in Japan: A cross-sectional survey.
    Hayama K; Fujita H; Iwatsuki K; Terui T
    J Dermatol; 2021 Feb; 48(2):203-206. PubMed ID: 33099802
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating Metabolomic Signature in Generalized Pustular Psoriasis Blunts Monocyte Hyperinflammation by Triggering Amino Acid Response.
    Yu N; Peng C; Chen W; Sun Z; Zheng J; Zhang S; Ding Y; Shi Y
    Front Immunol; 2021; 12():739514. PubMed ID: 34567002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.